nd efficient tools are urgently needed to treat patients in endemic countries. MAIN FACTS: - The partners will facilitate publication of the results to ensure access to the wider community of researchers focusing on neglected tropical diseases. - The public sector will benefit from the drugs developed through this agreement under the best possible conditions to ease access for patients in all endemic countries, irrespective of their level of economic development. - DNDi is a not-for-profit product development partnership working to research and develop new treatments for negleal cabinet is expected to make a final decision about the future of nuclear energy at a meeting June 6. The main features of its new energy policy, however, are clear after last night's meeting. At 0817 GMT RWE shares traded lower EUR1 or 2.4% at EUR40.25, while E.ON shares fell EUR0.36 or 1.85 to EUR19.66. Both shares underperformed a broadly firmer market. On Sunday night, Environment Minister Norbert Roettgen announced to reporters following a meeting with German Chancellor Angela Merkel that Germany would end the use of nuclear energy by 2022 at the very latest. The country's seven oldest nuclear reactors, which have been shut down since mid-March, will never resume power generation, the government said. An eighth power plant--the 1.4-gigawatt reactor Kruemmel that has been glitch-prone and offline for the best part of three years--will also be shut down permanently. The remaining reactors--except for three that will be kept as reserve capacity for an additional year to ensure that energy demand can be met--will be shut down by 2021. The government also said that it plans to keep the new tax on nuclear fuel rods that was introduced at the beginning of the year. The tax is expected to generate proceeds of around EUR2.3 billion per year and was officially introduced to help plug public budget holes. Many observers, however, have also linked the tax to the extension of reactor operating lives, for which the power plant operators had to